The Effects of Anti-Viral Therapy on the Clinical Status, Quality of Life, and Survival of Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Trial Profile

The Effects of Anti-Viral Therapy on the Clinical Status, Quality of Life, and Survival of Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Recruiting
Phase of Trial: Phase III

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary)
  • Indications Hepatitis C; Liver cirrhosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Mar 2018 Planned End Date changed from 1 Dec 2018 to 1 Feb 2019.
    • 15 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 01 Nov 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top